Presenting Germany’s drug pricing rule as a cost-per-QALY rule
Year of publication: |
2012
|
---|---|
Authors: | Gandjour, Afschin |
Published in: |
Health Care Management Science. - Springer, ISSN 1386-9620. - Vol. 15.2012, 2, p. 103-107
|
Publisher: |
Springer |
Subject: | Drug pricing | Germany | QALYs | Equity |
-
Q-ing for health : a new approach to eliciting the public's views on health care resource allocation
Baker, Rachel, (2014)
-
Accounting for consequences and claims in policy
Dolan, Paul, (2021)
-
The relative value of different QALY types
Lancsar, Emily, (2020)
- More ...
-
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic
Gandjour, Afschin, (2021)
-
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin, (2020)
-
Shaikh, Mujaheed, (2018)
- More ...